Mississippi is bracing for a surge in obesity rates — and launching new programs, policies and school initiatives to fight ...

In early 2025, the British Medical Journal (BMJ) reported 82 UK deaths from adverse reactions to semaglutide and tirzepatide, ...

Starting Jan. 1, New Hampshire’s Medicaid program will stop covering GLP-1 drugs — Wegovy, Zepbound, and others — for weight loss, the state Department of Health and Human Services told providers in ...

Starting Jan. 1, New Hampshire’s Medicaid program will stop covering GLP-1 drugs — Wegovy, Zepbound, and others — for weight loss. “We looked at the way that the state was supporting coverage for ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the way the U.N. agency has historically framed obesity treatment. The WHO ...

New World Health Organization guidelines for GLP-1 weight-loss drugs state that “intensive behavioral therapy” should be combined with these revolutionizing medications for obesity treatment. In the ...

A Wisconsin teen was allegedly starved by morbidly obese family members. The severely malnourished teen was found 'gravely ill.' Your neighbors may be driving up your utility bill—watch out for this ...

Weight-loss drugs are coming for a new kind of customer. “You don’t need to be obese to start a GLP-1,” reads an ad from a telehealth startup, the words scrawled in icing on a cake. Another one ...

New obesity standards focus on belly fat and body composition, affecting men and Asian individuals most dramatically according to recent research. Republicans dumbfounded by Trump’s calls for harsh ...

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach that would bypass traditional drug sales channels in an effort to expand ...